Work

A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma.

Year: 1991

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1991.9.4.641

Authors: J P Dutcher, E R Gaynor, D H Boldt, J H Doroshow, M H Bar, M Sznol, J Mier, J Sparano, R I Fisher, G Weiss

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Yeshiva University

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1105070095, G1505869703, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES, G2197280113, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES

OpenAlex ID: W1904429763

FWCI: 5.634

Cites: 10

Cited by: 99

Related to: 10